DUSP1 and prostate small cell carcinoma: Some studies have shown the aberrant expression status of DUSP1 in malignant tumours such as prostate small cell carcinoma [44], liver cancer [45], and non-small cell lung cancer [46], which may affect the therapeutic effect of chemotherapeutic drugs.